Withuspharmaceutical Return On Asset vs. Current Ratio
| 330350 Stock | KRW 6,660 80.00 1.19% |
For Withuspharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Withuspharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Withuspharmaceutical CoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Withuspharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Withuspharmaceutical CoLtd over time as well as its relative position and ranking within its peers.
Withuspharmaceutical |
Withuspharmaceutical Current Ratio vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Withuspharmaceutical's current stock value. Our valuation model uses many indicators to compare Withuspharmaceutical value to that of its competitors to determine the firm's financial worth. Withuspharmaceutical CoLtd is rated third in return on asset category among its peers. It is rated fourth in current ratio category among its peers fabricating about 54.82 of Current Ratio per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Withuspharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Withuspharmaceutical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Withuspharmaceutical Current Ratio vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Withuspharmaceutical |
| = | 0.0664 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Withuspharmaceutical |
| = | 3.64 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Withuspharmaceutical Current Ratio Comparison
Withuspharmaceutical is rated third in current ratio category among its peers.
Withuspharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Withuspharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Withuspharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Withuspharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Withuspharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Withus Pharmaceutical Co., Ltd. produces and sells pharmaceutical products in South Korea. The company was founded in 2005 and is headquartered in Seoul, South Korea. Withus Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Withuspharmaceutical Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Withuspharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Withuspharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Withuspharmaceutical's important profitability drivers and their relationship over time.
Use Withuspharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Withuspharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Withuspharmaceutical will appreciate offsetting losses from the drop in the long position's value.Withuspharmaceutical Pair Trading
Withuspharmaceutical CoLtd Pair Trading Analysis
The ability to find closely correlated positions to Withuspharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Withuspharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Withuspharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Withuspharmaceutical CoLtd to buy it.
The correlation of Withuspharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Withuspharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Withuspharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Withuspharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Withuspharmaceutical position
In addition to having Withuspharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Robots And Drones Thematic Idea Now
Robots And Drones
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Withuspharmaceutical Stock
To fully project Withuspharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Withuspharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Withuspharmaceutical's income statement, its balance sheet, and the statement of cash flows.